KRAS and pancreatic neoplasm: Feature Selection (FS) technique and Qiagen's Ingenuity Pathway Analysis (IPA) were used to combine DNA‐Seq and RNA‐Seq data from mutant and wild‐type (WT) KRAS colon and pancreatic tumor samples.